JP2013522189A5 - - Google Patents

Download PDF

Info

Publication number
JP2013522189A5
JP2013522189A5 JP2012557010A JP2012557010A JP2013522189A5 JP 2013522189 A5 JP2013522189 A5 JP 2013522189A5 JP 2012557010 A JP2012557010 A JP 2012557010A JP 2012557010 A JP2012557010 A JP 2012557010A JP 2013522189 A5 JP2013522189 A5 JP 2013522189A5
Authority
JP
Japan
Prior art keywords
flavonoid
anticancer drug
group
delivery vehicle
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012557010A
Other languages
English (en)
Japanese (ja)
Other versions
JP5954877B2 (ja
JP2013522189A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SG2011/000100 external-priority patent/WO2011112156A1/en
Publication of JP2013522189A publication Critical patent/JP2013522189A/ja
Publication of JP2013522189A5 publication Critical patent/JP2013522189A5/ja
Application granted granted Critical
Publication of JP5954877B2 publication Critical patent/JP5954877B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012557010A 2010-03-11 2011-03-11 負荷率の改善が可能な抗癌剤送達ビヒクル Expired - Fee Related JP5954877B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31288510P 2010-03-11 2010-03-11
US61/312,885 2010-03-11
PCT/SG2011/000100 WO2011112156A1 (en) 2010-03-11 2011-03-11 Anti-cancer agent delivery vehicles capable of improved laoding

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016053960A Division JP2016153415A (ja) 2010-03-11 2016-03-17 負荷率の改善が可能な抗癌剤送達ビヒクル

Publications (3)

Publication Number Publication Date
JP2013522189A JP2013522189A (ja) 2013-06-13
JP2013522189A5 true JP2013522189A5 (https=) 2014-04-24
JP5954877B2 JP5954877B2 (ja) 2016-07-20

Family

ID=44563737

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012557010A Expired - Fee Related JP5954877B2 (ja) 2010-03-11 2011-03-11 負荷率の改善が可能な抗癌剤送達ビヒクル
JP2016053960A Pending JP2016153415A (ja) 2010-03-11 2016-03-17 負荷率の改善が可能な抗癌剤送達ビヒクル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016053960A Pending JP2016153415A (ja) 2010-03-11 2016-03-17 負荷率の改善が可能な抗癌剤送達ビヒクル

Country Status (5)

Country Link
US (2) US9687464B2 (https=)
EP (1) EP2544768A4 (https=)
JP (2) JP5954877B2 (https=)
SG (2) SG184027A1 (https=)
WO (1) WO2011112156A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101694920B1 (ko) * 2007-10-23 2017-01-11 에이전시 포 사이언스, 테크놀로지 앤드 리서치 세포에 항암제를 전달하는 방법
EP2435504B1 (en) 2009-05-29 2020-03-11 Agency For Science, Technology And Research Flavonoid hydrogel
US8933078B2 (en) 2011-07-14 2015-01-13 Research Cancer Institute Of America Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
EP3041830B1 (en) 2013-09-03 2023-10-25 Agency For Science, Technology And Research Polymer-flavonoid conjugates and hydrogels for biomedical applications
MX2016014606A (es) * 2014-05-09 2017-08-24 Agency Science Tech & Res Un nanocomplejo micelar.
WO2015183970A1 (en) * 2014-05-28 2015-12-03 Stealth Peptides International, Inc. Therapeutic compositions including flavonoid and uses thereof
US9180226B1 (en) 2014-08-07 2015-11-10 Cook Medical Technologies Llc Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof
US9655998B2 (en) 2014-08-07 2017-05-23 Cook Medical Technologies Llc Encapsulated drug compositions and methods of use thereof
US11241520B2 (en) 2014-08-07 2022-02-08 Cook Medical Technologies Llc Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof
WO2018124970A1 (en) * 2016-12-30 2018-07-05 Agency For Science, Technology And Research A nanocomplex
US11890292B2 (en) 2017-02-27 2024-02-06 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
WO2018170457A1 (en) 2017-03-17 2018-09-20 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
US12213958B2 (en) 2017-11-17 2025-02-04 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
CN111973754A (zh) * 2019-05-21 2020-11-24 杭州磐田生物技术有限公司 含药物纳米颗粒及其制备方法和应用
EP4525922A1 (en) * 2022-05-16 2025-03-26 Suntec Medical, Inc. Method for treating autoimmune disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586612B2 (en) * 2001-11-16 2003-07-01 Crompton Corporation Process for the preparation of secondary and tertiary amino-functional silanes, iminoorganosilanes and/or imidoorganosilanes
AU2006248166B2 (en) 2005-05-20 2012-11-01 Agency For Science, Technology And Research Aldehyde conjugated flavonoid preparations
US7858080B2 (en) * 2005-05-20 2010-12-28 Agency For Science, Technology And Research Aldehyde conjugated flavonoid preparations
CA2648099C (en) * 2006-03-31 2012-05-29 The Brigham And Women's Hospital, Inc System for targeted delivery of therapeutic agents
KR101694920B1 (ko) * 2007-10-23 2017-01-11 에이전시 포 사이언스, 테크놀로지 앤드 리서치 세포에 항암제를 전달하는 방법
EP2435504B1 (en) 2009-05-29 2020-03-11 Agency For Science, Technology And Research Flavonoid hydrogel
EP2464388B1 (en) * 2009-08-11 2017-05-10 Agency for Science, Technology and Research Particulate hyaluronic acid formulations for cellular delivery of bioactive agents

Similar Documents

Publication Publication Date Title
JP2013522189A5 (https=)
Wang et al. Research status of dendrimer micelles in tumor therapy for drug delivery
Qiu et al. Preparation and application of calcium phosphate nanocarriers in drug delivery
Zhou et al. Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors
Gu et al. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy
Eldar-Boock et al. Nano-sized polymers and liposomes designed to deliver combination therapy for cancer
Wang et al. Tuning the architecture of polymeric conjugate to mediate intracellular delivery of pleiotropic curcumin
JP5954877B2 (ja) 負荷率の改善が可能な抗癌剤送達ビヒクル
ES2677327T3 (es) Método de administración de un agente anticanceroso a una célula
JP2012512175A5 (https=)
US20120231069A1 (en) Targeted Nanocarrier Systems for Delivery of Actives Across Biological Membranes
JP2011080089A5 (https=)
Kim et al. An injectable cell penetrable nano-polyplex hydrogel for localized siRNA delivery
Zhang et al. Synthesis and characterization of a new multifunctional polymeric prodrug paclitaxel–polyphosphoester–folic acid for targeted drug delivery
JP5692887B1 (ja) ポリマーミセル医薬組成物
Ward et al. Innovations in biomaterial design toward successful RNA interference therapy for cancer treatment
JP2013501781A (ja) 生体活性物質の細胞送達のための粒子状ヒアルロン酸製剤
WO2019006317A1 (en) PROGRAMMABLE THERMOSENSITIVE GELS
WO2011130716A2 (en) A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers
Giram et al. Poly (D, L-lactide-co-glycolide) surface-anchored biotin-loaded irinotecan nanoparticles for active targeting of colon cancer
Lin et al. Polymer nanoparticles advancements for gynecological cancers
CN107614019A (zh) 用于组合抗癌疗法的聚合物‑药物结合物
WO2018049017A1 (en) Block copolymer systems for local administration of toll-like receptor agonists
US9878049B2 (en) High drug loading system to co-deliver anticancer drugs and nucleic acids for cancer therapy
JP6892132B2 (ja) アミノチオール及びその類似体の改善された保護及び送達のための方法